首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1370564

哺乳動物多株抗體IgG 抗體市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Mammalian Polyclonal IgG Antibody Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

市場概況：

2022年，全球哺乳動物多株IgG抗體市場規模達到10.382億美元。展望未來，IMARC Group預計到2028年該市場將達到14.153億美元，2023-2028年年複合成長率（CAGR）為5.2%。

哺乳動物多株免疫球蛋白（IgG）抗體是指透過接種小鼠、兔子、山羊等多種哺乳動物而產生的抗原或疫苗。在此過程中，透過注射將抗原註入哺乳動物體內，以活化提供 IgG 的 B 淋巴細胞。這些抗體用於多種免疫測定測試中的標記試劑，包括酵素連結免疫吸附測定 (ELISA)、蛋白質印跡測試、免疫放射測定 (IRMA) 和放射免疫測定 (RIA)。除此之外，該過程不需要熟練的專業人員來生產大批量的疫苗。哺乳動物多克隆 IgG 抗體有助於創建多種療法、診斷各種疾病以及進行抗體鑑定和流式細胞儀。因此，他們在生化研究中發現了廣泛的應用，以檢測變性蛋白質並檢查疾病及其治療方法。目前，它們已以心臟、代謝和腎臟標記產品變體形式投入商業銷售。

哺乳動物多株抗體IgG 抗體市場趨勢：

包括癌症和自體免疫疾病在內的各種慢性疾病的盛行率不斷增加，以及研究環境中對多種免疫測定測試以及治療和分析應用的抗體的需求不斷增加，主要推動了市場的成長。與此一致的是，政府對生物技術和製藥公司進行大量投資，透過先進技術開發有效的新型疫苗和注射劑，這是另一個促進成長的因素。此外，生物製藥組織在品質控制（QC）方面不斷創新的創造性哺乳動物抗體也促進了市場的成長。此外，生物標記的批准不斷增加以及臨床醫生廣泛使用它們來準確、快速地診斷 B 細胞淋巴瘤和白血病，正在支持市場的成長。除此之外，醫療基礎設施和研發 (R&D) 活動的顯著增強，以提高抗體功效，正在為市場創造積極的前景。

本報告回答的關鍵問題

全球哺乳動物多克隆IgG抗體市場有多大？
2023-2028年全球哺乳動物多株IgG抗體市場的預期成長率是多少？
推動全球哺乳動物多克隆 IgG 抗體市場的關鍵因素是什麼？
COVID-19對全球哺乳動物多克隆IgG抗體市場有何影響？
全球哺乳動物多克隆 IgG 抗體市場按類型分類是怎樣的？
基於該產品的全球哺乳動物多克隆IgG抗體市場的詳細情形如何？
基於應用的全球哺乳動物多克隆 IgG 抗體市場的詳細情形如何？
根據最終用途，全球哺乳動物多克隆 IgG 抗體市場的詳細情形如何？
全球哺乳動物多克隆IgG抗體市場的關鍵區域有哪些？
全球哺乳動物多克隆 IgG 抗體市場的主要參與者/公司有哪些？

酵素連結免疫吸附試驗
- 市場走向
- 市場預測
免疫比濁法
- 市場走向
- 市場預測
免疫電泳
- 市場走向
- 市場預測
抗體鑑定
- 市場走向
- 市場預測
免疫組織化學
- 市場走向
- 市場預測
免疫細胞化學
- 市場走向
- 市場預測
蛋白質印跡法
- 市場走向
- 市場預測

第 9 章：依最終用途分類的市場區隔

醫院
- 市場走向
- 市場預測
診斷中心
- 市場走向
- 市場預測
學術及研究機構
- 市場走向
- 市場預測

第 10 章：按地區分類的市場細分

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbiotec Inc.
- Abcam plc
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- Creative Diagnostics
- Elabscience Biotechnology Inc.
- Geno Technology Inc.
- Merck KGaA
- Proteintech Group Inc.
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112023A6464

Abstract

Market Overview:

The global mammalian polyclonal IgG antibody market size reached US$ 1,038.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,415.3 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.

Mammalian polyclonal immunoglobulins (IgG) antibody refers to antigens or vaccinations that are manufactured through inoculation of various mammals, including mice, rabbits, and goats. During this procedure, an antigen is administered via injectable into the mammal body to activate the B-lymphocytes that supply IgG. These antibodies are used in labeling reagents in multiple immunoassay tests, including enzyme-linked immunosorbent assay (ELISA), western blot tests, immunoradiometric assay (IRMA), and radioimmunoassay (RIA). Apart from this, the process does not require skilled professionals to produce large batches of vaccinations. Mammalian polyclonal IgG antibody helps create multiple therapeutics, diagnose various ailments, and perform antibody identification and flow cytometry. As a result, they find extensive applications in biochemical research to detect denatured proteins and examine diseases and their treatments. At present, they are commercially available in cardiac, metabolic, and renal marker product variants.

Mammalian Polyclonal IgG Antibody Market Trends:

The increasing prevalence of various chronic disorders, including cancer and autoimmune ailments, and the rising need for antibodies for multiple immunoassay tests and therapeutic and analytical applications in research settings are primarily driving the market growth. In line with this, significant investments in biotechnology and pharmaceutical companies by governments to formulate effective novel vaccinations and injectables through advanced technologies are acting as another growth-inducing factor. Additionally, the ongoing innovation of creative mammalian antibodies by biopharma organizations for quality control (QC) is contributing to the market growth. Moreover, the escalating biomarkers approval and their extensive usage by clinicians for accurate and rapid diagnosis of B-cell lymphoma and leukemia are supporting the market growth. Apart from this, significant enhancements in the healthcare infrastructure and research and development (R&D) activities to enhance antibody efficacy are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global mammalian polyclonal IgG antibody market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product, application and end use.

Breakup by Type:

Goat

Rabbit

Horse

Mouse

Others

Breakup by Product:

Cardiac Markers

Metabolic Markers

Renal Markers

Others

Breakup by Application:

ELISA

Immunoturbidimetry

Immunoelectrophoresis

Antibody Identification

Immunohistochemistry

Immunocytochemistry

Western Blotting

Breakup by End Use:

Hospitals

Diagnostic Centers

Academic and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbiotec Inc., Abcam plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Creative Diagnostics, Elabscience Biotechnology Inc., Geno Technology Inc., Merck KGaA, Proteintech Group Inc., STEMCELL Technologies Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. How big is the global mammalian polyclonal IgG antibody market?
2. What is the expected growth rate of the global mammalian polyclonal IgG antibody market during 2023-2028?
3. What are the key factors driving the global mammalian polyclonal IgG antibody market?
4. What has been the impact of COVID-19 on the global mammalian polyclonal IgG antibody market?
5. What is the breakup of the global mammalian polyclonal IgG antibody market based on the type?
6. What is the breakup of the global mammalian polyclonal IgG antibody market based on the product?
7. What is the breakup of the global mammalian polyclonal IgG antibody market based on the application?
8. What is the breakup of the global mammalian polyclonal IgG antibody market based on the end use?
9. What are the key regions in the global mammalian polyclonal IgG antibody market?
10. Who are the key players/companies in the global mammalian polyclonal IgG antibody market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Mammalian Polyclonal IgG Antibody Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Goat
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Rabbit
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Horse
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Mouse
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Product

7.1 Cardiac Markers
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Metabolic Markers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Renal Markers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Application

8.1 ELISA
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Immunoturbidimetry
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Immunoelectrophoresis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Antibody Identification
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Immunohistochemistry
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Immunocytochemistry
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Western Blotting
- 8.7.1 Market Trends
- 8.7.2 Market Forecast

9 Market Breakup by End Use

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Diagnostic Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Academic and Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbiotec Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Abcam plc
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bio-Rad Laboratories Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Cell Signaling Technology Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Creative Diagnostics
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Elabscience Biotechnology Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Geno Technology Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Merck KGaA
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Proteintech Group Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 STEMCELL Technologies Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Mammalian Polyclonal IgG Antibody Market: Major Drivers and Challenges
Figure 2: Global: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Type (in %), 2022
Figure 5: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Product (in %), 2022
Figure 6: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Application (in %), 2022
Figure 7: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by End Use (in %), 2022
Figure 8: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Region (in %), 2022
Figure 9: Global: Mammalian Polyclonal IgG Antibody (Goat) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Mammalian Polyclonal IgG Antibody (Goat) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Mammalian Polyclonal IgG Antibody (Horse) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Mammalian Polyclonal IgG Antibody (Horse) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: North America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: North America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: United States: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: United States: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Canada: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Canada: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: China: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: China: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Japan: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Japan: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: India: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: India: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: South Korea: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: South Korea: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Australia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Australia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Indonesia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Indonesia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Europe: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Europe: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Germany: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Germany: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: France: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: France: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: United Kingdom: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: United Kingdom: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Italy: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Italy: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Spain: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Spain: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Russia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Russia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Latin America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Latin America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Brazil: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Brazil: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Mexico: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Mexico: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Breakup by Country (in %), 2022
Figure 95: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Global: Mammalian Polyclonal IgG Antibody Industry: SWOT Analysis
Figure 97: Global: Mammalian Polyclonal IgG Antibody Industry: Value Chain Analysis
Figure 98: Global: Mammalian Polyclonal IgG Antibody Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Mammalian Polyclonal IgG Antibody Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 6: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Mammalian Polyclonal IgG Antibody Market: Competitive Structure
Table 8: Global: Mammalian Polyclonal IgG Antibody Market: Key Players

02-2729-4219

+886-2-2729-4219